Fatigue News and Research

RSS

Chronic fatigue syndrome a public health epidemic says CDC

The Centers for Disease Control and Prevention (CDC) in the United States says more than a million Americans suffer from Chronic fatigue syndrome (CFS).

6 Nov 2006

Environment the culprit in women's higher risk of MS

Researchers in the UK are suggesting that there is an environmental link to the rising number of women being diagnosed with multiple sclerosis (MS) in Canada.

1 Nov 2006

Sad and lonely at bedtime - stress hormone up at dawn

According to a new study older people who go to bed lonely, sad or overwhelmed wake up the following morning with elevated levels of cortisol, the stress hormone linked to depression, obesity and other health problems.

31 Oct 2006

FDA approves Tyzeka for the treatment of adults with chronic hepatitis B

The Food and Drug Administration (FDA) has approved Tyzeka (telbivudine) for the treatment of adults with chronic hepatitis B (HBV), a serious viral infection that attacks the liver and can cause lifelong infection, scarring of the liver (cirrhosis), and eventually liver cancer, liver failure, and death.

26 Oct 2006

Mobile phone use should be banned in cars altogether

Hands-free mobile phones have failed to make the roads safer according to a University of Sussex psychologist.

23 Oct 2006

Tuberculosis fourfold the risk for Celiac sufferers

Swedish researchers are suggesting that people with celiac disease, also known as gluten intolerance, have an increased risk of developing tuberculosis (TB).

17 Oct 2006

Researchers identifiy how immune system contributes to nerve fiber damage caused by multiple sclerosis

Researchers have identified how the body's own immune system contributes to the nerve fiber damage caused by multiple sclerosis, a finding that can potentially aid earlier diagnosis and improved treatment for this chronic disease.

16 Oct 2006

Schizophrenia drug to be used to treat autism

A drug normally used to treat schizophrenia has been given approval by the U.S. the Food and Drug Administration for use in treating the symptoms of autism in children and adolescents.

9 Oct 2006

FDA approves Zolinza for the treatment of cutaneous T-cell lymphoma

The U.S. Food and Drug Administration (FDA) has approved Zolinza (vorinostat) capsules for the treatment of cutaneous T-cell lymphoma (CTCL), a type of skin cancer, to be used when the disease persists, gets worse, or comes back during or after treatment with other medicines.

8 Oct 2006

FDA approves Risperdal to treat irritability associated with autism

The U.S. Food and Drug Administration (FDA) has approved Risperdal (risperidone) orally disintegrating tablets, an adult antipsychotic drug, for the symptomatic treatment of irritability in autistic children and adolescents.

8 Oct 2006

FDA approves FluLaval

The U.S. Food and Drug Administration (FDA) today approved FluLaval, an influenza vaccine to immunize people 18 years of age and older against the disease caused by strains of influenza virus judged likely to cause seasonal flu in the Northern Hemisphere in 2006-2007.

5 Oct 2006

Nicotinamide may help people with multiple sclerosis

Researchers have found a possible way to protect people with multiple sclerosis (MS) from severe long-term disability: increase nervous-system levels of a vital compound, called nicotinamide adenine dinucleotide (NAD), by giving its chemical precursor - nicotinamide, a form of vitamin B3.

19 Sep 2006

Study compares sprint versus endurance training

Those who maintain that the busy pace of life offers no time to exercise have just run out of another excuse, unless of course they can't spare three minutes to exercise.

19 Sep 2006

New campaign to educate about peripheral arterial disease

More than 8 million men and women - one in 20 adults - have peripheral arterial disease (P.A.D), a largely unrecognized condition which puts them at risk for heart attack and stroke.

13 Sep 2006

Genetic link to chronic fatigue

Unexplained disabling fatigue in childhood is mainly due to genetic inheritance, a study of twins has revealed.

7 Sep 2006

Closing in on lethal arrhythmogenic right ventricular dysplasia in young athletes

Johns Hopkins experts on the genetics of a potentially lethal heart rhythm defect that runs in families and targets young athletes report they have greatly narrowed the hunt for the specific genetic mutations that contribute to the problem.

7 Sep 2006

Report questions CMS Cancer Care Research Program

HHS inspector general Daniel Levinson in a report released on Wednesday questioned the legitimacy of a one-year research program conducted by CMS in which the federal government and Medicare beneficiaries paid oncologists a total of about $275 million to report information on chemotherapy side effects that might lead to improved care for cancer patients, the AP/South Florida Sun Sentinel reports.

30 Aug 2006

Long-term health effects from West Nile illnesses

More than a year after being diagnosed with a West Nile virus infection, half of the patients have ongoing health complaints including fatigue, memory problems, headaches, depression, and tremors, according to an article in the Sept. 15 issue of Clinical Infectious Diseases.

16 Aug 2006

Majority of pregnant women with depression not receiving treatment

The majority of pregnant women who have full-blown major depression aren't getting any treatment for the condition, and neither are most pregnant women who have signs of milder depression or depression risk.

14 Aug 2006

Little known about the impacts of cancer on the Australian workforce

Thirty seven thousand Australians aged 20-64 years of age were diagnosed with cancer in 2001 yet surprisingly little is known about the impacts of cancer on the Australian workforce.

8 Aug 2006